SAMHSA


SAMHSA Backs Away From TeenScreen & TMAP Mon, 24 Oct 2005 On October 17, a meeting took place with Charles Currie in Washington DC – with some in attendance by conference call. Currie is the Administrator of the Substance Abuse and Mental Health Services Administration (SAMHSA), the federal agency charged […]

SAMHSA Backs Away From TeenScreen & TMAP


APA Claims Credit for Censoring News Report about Mental Screening Sun, 16 Oct 2005 The American Psychiatric Association acknowledges its role in suppressing a major news story about the President’s New Freedom Commission Report recommendation. That recommendation is the center of a heated debate among advocates for personal privacy, parental […]

APA Claims Credit for Censoring News Report about Mental Screening


Janssen Pharma Admits Hiding Risperdal Drug Risks / TMAP & Illinois Mental Health Screening Plan Sat, 24 Jul 2004 The Miami Herald reports (below) that in a letter to doctors, Janssen Pharmacia, manufacturer of the highly promoted drug, Risperdal (risperidone), admitted “misleading doctors and other healthcare providers about the safety […]

Janssen Admits Hiding Risperdal Risks / TMAP & Illinois Mental ...



Take Action: Just Say No to Stigmatizing Screening and Unsafe Drugs Tue, 26 Oct 2004 FYI /ACTION! AHRP believes that America’s school children should not be screened and labeled without a guarantee of the proven accuracy of the screening tool, and the proven safety and therapeutic value of the treatment […]

Take Action: Just Say No to Stigmatizing Screening and Unsafe ...





TeenScreen: Who Pays for Treatment and Drugs?? Sun, 29 May 2005 In her latest examination of the President’s Commission on Mental Health recommendation for universal mental health screening, Evelyn Pringle focuses on the $$$ it costs and on how screening, followed by prescribing psychotropic drugs, is bankrupting of public health […]

TeenScreen: Who Pays for Treatment and Drugs??


AHRP Position Statement on Mental Health Screening – FDA Hearing Re: Drug Advertising Wed, 02 Nov 2005 FDA is holding public hearings (Nov 1, 2) Re:  Direct-to-Consumer Promotion of Medical Products at: National Transportation Safety Board Boardroom and Conference Center 429 L’Enfant Plaza, SW., Washington, DC 2 Time: 9:00 –5:00. […]

AHRP Position Statement on Mental Health Screening – FDA Hearing ...